Recruiting
Phase 1

Eribulin & Zanzalintinib

Sponsor:

Washington University School of Medicine

Code:

NCT06957431

Conditions

Advanced Leiomyosarcoma

Adipocytic Sarcoma

Advanced Liposarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanzalintinib

Eribulin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2025-10-24.